Surface Oncology Inc reports results for the quarter ended in September - Earnings Summary

Surface Oncology

08/11/2021 14:31

* Surface Oncology Inc  SURF.OQ  reported a quarterly adjusted
loss of 44 cents​​ per share for the quarter ended in September.
The mean expectation of six analysts for the quarter was for a
loss of 40 cents per share.
* Revenue was $392.00 thousand​;  analysts expected $2.05
million. 
* Surface Oncology Inc's reported EPS for the quarter was a loss
of 44 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Surface Oncology Inc shares had fallen by 0.7% this
quarter and lost 18.6% so far this year.
* The company reported a quarterly loss of $19.89 million.
* Wall Street's median 12-month price target for Surface
Oncology Inc is $17.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 8 at 02:30 p.m.
 ​All figures in US dollars unless otherwise stated